FILTRACE Trademark

Trademark Overview

On Friday, August 14, 2020, a trademark application was filed for FILTRACE with the United States Patent and Trademark Office. The USPTO has given the FILTRACE trademark a serial number of 90115193. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, July 31, 2023. This trademark is owned by MediBeacon Inc.. The FILTRACE trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic agents, namely, tracer agents for medical diagnostic imaging purposes
filtrace

General Information

Serial Number90115193
Word MarkFILTRACE
Filing DateFriday, August 14, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, July 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements

Goods and ServicesDiagnostic agents, namely, tracer agents for medical diagnostic imaging purposes
Translation of Words in MarkThe English translation of "FILTRACE" in the mark is "FILTRATION".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMediBeacon Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63141
Party NameMediBeacon Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63132

Trademark Events

Event DateEvent Description
Tuesday, August 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 31, 2023SOU EXTENSION 5 GRANTED
Friday, July 21, 2023SOU EXTENSION 5 FILED
Monday, July 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 21, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2023SOU EXTENSION 4 GRANTED
Tuesday, February 7, 2023SOU EXTENSION 4 FILED
Tuesday, February 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 23, 2022SOU EXTENSION 3 GRANTED
Tuesday, August 23, 2022SOU EXTENSION 3 FILED
Tuesday, August 23, 2022SOU TEAS EXTENSION RECEIVED
Saturday, February 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 10, 2022SOU EXTENSION 2 GRANTED
Thursday, February 10, 2022SOU EXTENSION 2 FILED
Thursday, February 10, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 20, 2021SOU EXTENSION 1 GRANTED
Friday, August 20, 2021SOU EXTENSION 1 FILED
Friday, August 20, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 9, 2020ASSIGNED TO EXAMINER
Thursday, September 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 18, 2020NEW APPLICATION ENTERED

Related Keywords

filtrace diagnostic agents imaging purposes tracer namely medical